ProfileGDS4718 / 223228_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 91% 96% 94% 90% 92% 94% 92% 94% 92% 92% 92% 90% 93% 89% 88% 91% 87% 93% 86% 90% 93% 93% 91% 90% 93% 93% 89% 90% 94% 87% 93% 93% 90% 87% 91% 94% 91% 91% 96% 91% 90% 92% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.7906793
GSM549102patient 115, normal, homogenized [OPG study]9.2526791
GSM549104patient 119, normal, homogenized [OPG study]10.727396
GSM549108patient 138, normal, homogenized [OPG study]9.8291994
GSM549119patient 077, normal, homogenized [OPG study]9.1933790
GSM549133patient 032, cancer, homogenized [OPG study]9.6155892
GSM549139patient 042, cancer, homogenized [OPG study]10.006494
GSM549099patient 107, normal, homogenized [OPG study]9.542392
GSM549109patient 139, normal, homogenized [OPG study]10.040794
GSM549110patient 046, normal, homogenized [OPG study]9.5853492
GSM549114patient 063, normal, homogenized [OPG study]9.6531792
GSM549122patient 082, normal, homogenized [OPG study]9.6114992
GSM549134patient 033, cancer, homogenized [OPG study]9.1303390
GSM549136patient 036, cancer, homogenized [OPG study]9.7793393
GSM549140patient 044, cancer, homogenized [OPG study]9.1336489
GSM549111patient 047, normal, homogenized [OPG study]8.9645988
GSM549113patient 057, normal, homogenized [OPG study]9.6513791
GSM549132patient 031, cancer, homogenized [OPG study]8.7530387
GSM549137patient 038, cancer, homogenized [OPG study]9.7547993
GSM549142patient 047, cancer, homogenized [OPG study]8.2132586
GSM549100patient 110, normal, homogenized [OPG study]9.1018890
GSM549107patient 135, normal, homogenized [OPG study]9.8544893
GSM549115patient 068, normal, homogenized [OPG study]9.8941193
GSM549116patient 072, normal, homogenized [OPG study]9.4887691
GSM549120patient 078, normal, homogenized [OPG study]9.2147990
GSM549131patient 030, cancer, homogenized [OPG study]9.8661593
GSM549118patient 074, normal, homogenized [OPG study]9.7490693
GSM549129patient 027, cancer, homogenized [OPG study]8.9998789
GSM549123patient 088, normal, homogenized [OPG study]9.3246290
GSM549124patient 006, cancer, homogenized [OPG study]9.7787194
GSM549126patient 015, cancer, homogenized [OPG study]8.6983487
GSM549128patient 025, cancer, homogenized [OPG study]9.7787293
GSM549103patient 117, normal, homogenized [OPG study]9.5973393
GSM549117patient 073, normal, homogenized [OPG study]9.3876790
GSM549138patient 041, cancer, homogenized [OPG study]8.7032487
GSM549141patient 045, cancer, homogenized [OPG study]9.5015891
GSM549130patient 028, cancer, homogenized [OPG study]9.719894
GSM549101patient 111, normal, homogenized [OPG study]9.3825791
GSM549105patient 128, normal, homogenized [OPG study]9.4245891
GSM549106patient 134, normal, homogenized [OPG study]10.853396
GSM549112patient 048, normal, homogenized [OPG study]9.4257391
GSM549125patient 011, cancer, homogenized [OPG study]9.206790
GSM549127patient 024, cancer, homogenized [OPG study]9.4090792
GSM549135patient 035, cancer, homogenized [OPG study]9.5401492